Markets:

Overview

News

Currencies

International

Treasuries

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

2.665 -0.025 (-0.93%)

Streaming Delayed Price Updated: 11:08 AM EDT, Sep 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CytomX Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

Via Investor Brand Network

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:VRTX),(NASDAQ:IBRX),(NASDAQ:CRSP),(NASDAQ:CTMX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - A Strong Contender in High-Growth Biotech ↗

July 08, 2025

CYTOMX THERAPEUTICS (CTMX) meets Minervini’s trend criteria with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.

Via Chartmill

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Exploring CytomX Therapeutics's Earnings Expectations ↗

May 09, 2025

Via Benzinga

(CTMX) - Analyzing CytomX Therapeutics's Short Interest ↗

June 05, 2024

Via Benzinga

Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday ↗

May 28, 2025

Via Benzinga

CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

May 20, 2025

Via Benzinga

This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday ↗

May 15, 2025

Via Benzinga

CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drug ↗

May 12, 2025

The company shared Phase 1 trial results for CX-2051, an antibody-drug conjugate for advanced colorectal cancer, with 28% of patients achieving confirmed partial responses.

Via Stocktwits

Top movers analysis one hour before the close of the markets on 2025-05-12: top gainers and losers in today's session. ↗

May 12, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Monday's session: most active stocks ↗

May 12, 2025

These stocks are making the most noise in today's session. Stay tuned for the latest updates!

Via Chartmill

Stocks Under $1 to Watch: TAOP, WLGS, HIT, CTMX, JYD – Major Updates, Earnings & Offerings, More Inside….

May 12, 2025

Via AB Newswire

Topics Economy

Which stocks are moving on Monday? ↗

May 12, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 12, 2025

Via Benzinga

These stocks are gapping in today's session ↗

May 12, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report ↗

May 12, 2025

CytomX reported early Phase 1 data for CX-2051 in advanced colorectal cancer, with a 94% disease control rate.

Via Benzinga

Top movers in Monday's pre-market session ↗

May 12, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 12, 2025

Via Benzinga

Wondering what's happening in today's pre-market session? ↗

May 09, 2025

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 09, 2025

Via Benzinga

These stocks are gapping in today's session ↗

May 05, 2025

The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

April 28, 2025

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 28, 2025

Via Benzinga

Which stocks have an unusual volume on Monday? ↗

March 10, 2025

Which stocks have an unusual volume on Monday?

Via Chartmill

Friday's pre-market session: top gainers and losers ↗

March 07, 2025

As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

March 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

CTMX stock results show that CytomX Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Earnings Scheduled For March 6, 2025 ↗

March 06, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.